We create unparalleled partnerships with our clients to develop life-changing therapeutics, tests, and processes to support our mission of saving lives through enhanced patient care.
Through our expertise, customization, and scalability, NeoGenomics supports clients in cancer-related market segments, including hospital and private pathology laboratories, office-based oncologists, academic institutions, contract research and pharmaceutical development organizations, and more. We are tirelessly pushing the boundaries and improving our capabilities to provide our partners with the most technologically advanced testing available, integrating the latest clinical evidence and guidelines to advance the care of all patients.
- Leadership
- Board of Directors
- Medical & Scientific
- Scientific Advisory Board

Chris Smith
Chief Executive Officer
Read Bio

Jeff Sherman
Chief Financial Officer
Read Bio

Warren Stone
President Clinical Division
Read Bio

Vishal Sikri
President, Advanced Diagnostics Division
Read Bio

Melody Harris
President Enterprise Operations
Read Bio

Ali Olivo
General Counsel and Corporate Secretary
Read Bio

Hutan Hashemi, JD
Chief Compliance Officer
Read Bio

Greg Sparks
Chief Technology Officer
Read Bio

Gary Passman
Chief Culture Officer
Read Bio